Biomolecular Life Holdings, Inc. (USOTC:BIOM) announced that it has agreed to acquire land in Llanogrande, Rionegro, Colombia, for the development of a wellness and longevity retreat combining biomolecular technologies, personalised wellness programmes and hospitality services.
The proposed facility will be located approximately 10 minutes from José María Córdova International Airport, which serves Medellín and the surrounding region.
Construction is expected to begin in January 2027, with an opening targeted for the first quarter of 2028, subject to financing, permits, regulatory approvals and construction schedules.
Land Acquisition Structured as Related-Party Transaction
The property is currently owned by BSD SAS, a Colombian company controlled by Jessika Wiesner, President and Chief Executive Officer of Biomolecular Life Holdings.
The proposed acquisition will be completed through an all-stock transaction, with the number of shares issued determined by an independent property appraisal.
As the seller is controlled by the company’s chief executive, the acquisition constitutes a related-party transaction.
Biomolecular Life expects the share-based structure to preserve cash for the development of the planned facility.
The company has not disclosed the property’s valuation or the number of shares expected to be issued.
Planned Retreat to Combine Wellness Services and Hospitality
The proposed Biomolecular Wellness Spa and Longevity Retreat is intended to serve domestic and international visitors seeking personalised wellness experiences.
Subject to regulatory approvals and operational development, the facility could offer biomolecular wellness programmes, nutritional guidance, preventive health services, relaxation treatments and multi-day retreats.
The development is also expected to incorporate accommodation and sales of products from the Biomolecular Life nutraceutical range.
The company has previously signed a letter of intent to acquire Biomolecular Life LLC, which is associated with the nutritional product line.
Llanogrande, located in Colombia’s Antioquia region, was selected for its proximity to Medellín’s international airport and its established residential and hospitality market.
Development Scheduled to Begin in Early 2027
Biomolecular Life intends to establish the property as a permanent location for its wellness and longevity services, with potential for further expansion of its product and service offerings.
Wiesner said the company aims to develop a destination combining personalised wellness programmes, biomolecular technologies and preventive health services.
The planned development forms part of Biomolecular Life’s broader strategy to expand its wellness operations in Colombia and serve international visitors.
The company has not disclosed the total projected construction cost, financing arrangements or expected revenue from the proposed retreat.
Completion of the land acquisition and development remains subject to the applicable transaction and project requirements.